Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

UroGen Pharma (URGN) Shares Outstanding: 2016-2025

Historic Shares Outstanding for UroGen Pharma (URGN) over the last 8 years, with Sep 2025 value amounting to $46.8 million.

  • UroGen Pharma's Shares Outstanding rose 10.88% to $46.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.8 million, marking a year-over-year increase of 10.88%. This contributed to the annual value of $42.2 million for FY2024, which is 29.98% up from last year.
  • As of Q3 2025, UroGen Pharma's Shares Outstanding stood at $46.8 million, which was up 1.26% from $46.2 million recorded in Q2 2025.
  • UroGen Pharma's 5-year Shares Outstanding high stood at $46.8 million for Q3 2025, and its period low was $22.3 million during Q1 2021.
  • For the 3-year period, UroGen Pharma's Shares Outstanding averaged around $37.4 million, with its median value being $41.2 million (2024).
  • Data for UroGen Pharma's Shares Outstanding shows a peak YoY skyrocketed of 75.20% (in 2024) over the last 5 years.
  • Over the past 5 years, UroGen Pharma's Shares Outstanding (Quarterly) stood at $22.5 million in 2021, then climbed by 2.97% to $23.1 million in 2022, then soared by 40.47% to $32.5 million in 2023, then climbed by 29.98% to $42.2 million in 2024, then climbed by 10.88% to $46.8 million in 2025.
  • Its Shares Outstanding was $46.8 million in Q3 2025, compared to $46.2 million in Q2 2025 and $46.1 million in Q1 2025.